1. Detection of Host Cell Gene/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer
    Lingyi Zhang et al, 2022, Frontiers in Oncology CrossRef
  2. Oncogenic Virus-Induced Oxidative Stress and Epigenetic Regulation: An Insight into Host DNA Methylation
    Isha Sengupta et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
  3. 5-aza-2′-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells
    Maximilian Stich et al, 2017, Oncotarget CrossRef
  4. 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression
    Adrien Morel et al, 2017, Oncotarget CrossRef
  5. HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation
    Lulu Yu et al, 2022, International Journal of Molecular Sciences CrossRef
  6. FBXL7 Body Hypomethylation Is Frequent in Tumors from the Digestive and Respiratory Tracts and Is Associated with Risk-Factor Exposure
    Diego Camuzi et al, 2022, International Journal of Molecular Sciences CrossRef
  7. A miR-199a/miR-214 Self-Regulatory Network via PSMD10, TP53 and DNMT1 in Testicular Germ Cell Tumor
    Bi-Feng Chen et al, 2014, Scientific Reports CrossRef
  8. Epigenetic approaches for cervical neoplasia screening (Review)
    Adrian Albulescu et al, 2021, Experimental and Therapeutic Medicine CrossRef
  9. The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation
    James A. Scarth et al, 2021, Journal of General Virology CrossRef
  10. Association Study Between Methylation in the Promoter Regions of cGAS, MAVS, and TRAF3 Genes and the Risk of Cervical Precancerous Lesions and Cervical Cancer in a Southern Chinese Population
    Shiqi Huang et al, 2019, Frontiers in Genetics CrossRef
  11. LSD1 binds to HPV16 E7 and promotes the epithelial-mesenchymal transition in cervical cancer by demethylating histones at the Vimentin promoter
    Yuan Liu et al, 2017, Oncotarget CrossRef
  12. “From molecular to clinic”: The pivotal role of CDC42 in pathophysiology of human papilloma virus related cancers and a correlated sensitivity of afatinib
    Erdong Wei et al, 2023, Frontiers in Immunology CrossRef

  13. DNMT1 Enhances the Radiosensitivity of HPV-Positive Head and Neck Squamous Cell Carcinomas via Downregulating SMG1


    Chunlin Zhang et al, 2020, OncoTargets and Therapy CrossRef
  14. Epigenetic Regulation of the Human Papillomavirus Life Cycle
    Michelle Mac et al, 2020, Pathogens CrossRef
  15. Oncogenic Virus-Induced Oxidative Stress and Epigenetic Regulation: An Insight into Host DNA Methylation
    Isha Sengupta et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
  16. A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma
    Neil Ari Wijetunga et al, 2016, Oncotarget CrossRef
  17. Molecular Pap Smear: Validation of HPV Genotype and Host Methylation Profiles of ADCY8, CDH8, and ZNF582 as a Predictor of Cervical Cytopathology
    Jane Shen-Gunther et al, 2020, Frontiers in Microbiology CrossRef
  18. Association between promoter methylation and gene expression of CGB3 and NOP56 in HPV‑infected cervical cancer cells
    Palak Singh et al, 2021, Biomedical Reports CrossRef
  19. High nuclear expression of DNMT1 in correlation with inactivation of TET1 portray worst prognosis among the cervical carcinoma patients: clinical implications
    Priyanka Dutta et al, 2023, Journal of Molecular Histology CrossRef
  20. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3
    Chi Lam Au Yeung et al, 2017, Oncotarget CrossRef